Evidence map›Paper›PMID 31663683›Full record

ArticleCancer medicine2019

Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER database.

Kaiwen Shen, Longdi Yao, Jinli Wei, Zhou Luo, Wang Yu, Huamin Zhai, Jianwen Wang, Luhong Chen, Deyuan Fu

Abstract read
In one paragraph

Article in Cancer medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kaiwen ShenYangzhou University Medical Academy, Yangzhou, Jiangsu, China.
Longdi YaoThe Second Clinical College of Dalian Medical University, Dalian, Liaoning, China.
Jinli WeiDepartment of Thyroid and Breast Surgery, Yangzhou University Affiliated Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China.ORCID 0000-0001-8654-8787
Zhou LuoDepartment of Thyroid and Breast Surgery, Yangzhou University Affiliated Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China.
Wang YuDepartment of Thyroid and Breast Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Huamin ZhaiYangzhou University Medical Academy, Yangzhou, Jiangsu, China.
Jianwen WangYangzhou University Medical Academy, Yangzhou, Jiangsu, China.
Luhong ChenYangzhou University Medical Academy, Yangzhou, Jiangsu, China.
Deyuan FuYangzhou University Medical Academy, Yangzhou, Jiangsu, China.ORCID 0000-0003-3636-399X

Funding

National Natural Science Foundation of China 81772516
6 · The paper itself

Abstract

objectiveThere is limited information from population-based cancer registries regarding prognostic features of bilateral primary breast cancer (BPBC).

methodsFemale patients diagnosed with BPBC between 2004 and 2014 were randomly divided into training (n = 7740) and validation (n = 2579) cohorts from the Surveillance, Epidemiology, and End Results Database. We proposed five various models. Multivariate Cox hazard regression and competing risk analysis were to explore prognosis factors in training cohort. Competing risk nomograms were constructed to combine significant prognostic factors to predict the 3-year and the 5-year survival of patients with BPBC. At last, in the validation cohort, the new score performance was evaluated with respect to the area under curve, concordance index, net reclassification index and calibration curve.

resultsWe found out that age, interval time, lymph nodes invasion, tumor size, tumor grade and estrogen receptor status were independent prognostic factors in both multivariate Cox hazard regression analysis and competing risk analysis. Concordance index in the model of the worse characteristics was 0.816 (95% CI: 0.791-0.840), of the bilateral tumors was 0.819 (95% CI: 0.793-0.844), of the worse tumor was 0.807 (0.782-0.832), of the first tumor was 0.744 (0.728-0.763) and of the second tumor was 0.778 (0.762-0.794). Net reclassification index of the 3-year and the 5-year between them was 2.7% and -1.0%. The calibration curves showed high concordance between the nomogram prediction and actual observation.

conclusionThe prognosis of BPBC depended on bilateral tumors. The competing risk nomogram of the model of the worse characteristics may help clinicians predict survival simply and effectively. Metachronous bilateral breast cancer presented poorer survival than synchronous bilateral breast cancer.

Indexed as

AgedBiomarkers, TumorBreast NeoplasmsFemaleHumansMiddle AgedNomogramsPrognosisProportional Hazards ModelsReproducibility of ResultsRisk AssessmentRisk FactorsROC CurveSEER ProgramTumor BurdenBiomarkers, Tumorbilateral breast neoplasmend results (SEER) databaseepidemiologynomogramsprognosissurveillance

Identifiers

PMID31663683
PMCPMC6912037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.